Response to adjuvant therapy with potassium perchlorate in amiodarone-induced thyrotoxicosis : observations on three cases
Copyright © 2010 SEEN. Published by Elsevier Espana. All rights reserved..
INTRODUCTION: Amiodarone-induced thyrotoxicosis (AIT) is a common clinical disorder that may be life threatening and whose clinical manifestations and response to treatment may vary among patients.
METHODS: We present three patients treated with amiodarone for atrial fibrillation who developed AIT at least 36 months after beginning the treatment. Thyrotoxicosis worsened the underlying cardiac disorders and was resistant to treatment based on the combination of dexamethasone 8-12 mg/day i.v., thioamides 45 mg/day p.o., beta blockers and potassium perchlorate at doses of 800 to 1000 mg per day p.o. Two of the patients attained sustained euthyroidism after 12 and 32 days of combined treatment, while the third required total thyroidectomy.
CONCLUSION: The combination of thioamides with potassium perchlorate is an appropriate form of therapy for AIT in patients resistant to thioamides. The use of this combination should be evaluated in patients with mixed AIT or AIT of unclear etiology.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2011 |
---|---|
Erschienen: |
2011 |
Enthalten in: |
Zur Gesamtaufnahme - volume:58 |
---|---|
Enthalten in: |
Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion - 58(2011), 3 vom: 01. März, Seite 121-6 |
Sprache: |
Spanisch |
---|
Weiterer Titel: |
A propósito de tres casos. Respuesta a la terapia adyuvante con perclorato potásico en la tirotoxicosis inducida por amiodarona |
---|
Beteiligte Personen: |
Arias, Nieves [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 25.07.2011 Date Revised 20.11.2014 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.endonu.2010.12.002 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM206288735 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM206288735 | ||
003 | DE-627 | ||
005 | 20231223235620.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231223s2011 xx |||||o 00| ||spa c | ||
024 | 7 | |a 10.1016/j.endonu.2010.12.002 |2 doi | |
028 | 5 | 2 | |a pubmed24n0688.xml |
035 | |a (DE-627)NLM206288735 | ||
035 | |a (NLM)21367680 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a spa | ||
100 | 1 | |a Arias, Nieves |e verfasserin |4 aut | |
245 | 1 | 0 | |a Response to adjuvant therapy with potassium perchlorate in amiodarone-induced thyrotoxicosis |b observations on three cases |
246 | 3 | 3 | |a A propósito de tres casos. Respuesta a la terapia adyuvante con perclorato potásico en la tirotoxicosis inducida por amiodarona |
264 | 1 | |c 2011 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 25.07.2011 | ||
500 | |a Date Revised 20.11.2014 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2010 SEEN. Published by Elsevier Espana. All rights reserved. | ||
520 | |a INTRODUCTION: Amiodarone-induced thyrotoxicosis (AIT) is a common clinical disorder that may be life threatening and whose clinical manifestations and response to treatment may vary among patients | ||
520 | |a METHODS: We present three patients treated with amiodarone for atrial fibrillation who developed AIT at least 36 months after beginning the treatment. Thyrotoxicosis worsened the underlying cardiac disorders and was resistant to treatment based on the combination of dexamethasone 8-12 mg/day i.v., thioamides 45 mg/day p.o., beta blockers and potassium perchlorate at doses of 800 to 1000 mg per day p.o. Two of the patients attained sustained euthyroidism after 12 and 32 days of combined treatment, while the third required total thyroidectomy | ||
520 | |a CONCLUSION: The combination of thioamides with potassium perchlorate is an appropriate form of therapy for AIT in patients resistant to thioamides. The use of this combination should be evaluated in patients with mixed AIT or AIT of unclear etiology | ||
650 | 4 | |a Case Reports | |
650 | 4 | |a English Abstract | |
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 7 | |a Adrenergic beta-Antagonists |2 NLM | |
650 | 7 | |a Cardiovascular Agents |2 NLM | |
650 | 7 | |a Perchlorates |2 NLM | |
650 | 7 | |a Potassium Compounds |2 NLM | |
650 | 7 | |a Thioamides |2 NLM | |
650 | 7 | |a Thyroid Hormones |2 NLM | |
650 | 7 | |a potassium perchlorate |2 NLM | |
650 | 7 | |a 42255P5X4D |2 NLM | |
650 | 7 | |a Dexamethasone |2 NLM | |
650 | 7 | |a 7S5I7G3JQL |2 NLM | |
650 | 7 | |a Thyrotropin |2 NLM | |
650 | 7 | |a 9002-71-5 |2 NLM | |
650 | 7 | |a Acenocoumarol |2 NLM | |
650 | 7 | |a I6WP63U32H |2 NLM | |
650 | 7 | |a Amiodarone |2 NLM | |
650 | 7 | |a N3RQ532IUT |2 NLM | |
700 | 1 | |a Moreno-Pérez, Óscar |e verfasserin |4 aut | |
700 | 1 | |a Boix, Evangelina |e verfasserin |4 aut | |
700 | 1 | |a Serrano, Joaquín |e verfasserin |4 aut | |
700 | 1 | |a Revert, Paula |e verfasserin |4 aut | |
700 | 1 | |a González, Víctor L |e verfasserin |4 aut | |
700 | 1 | |a Sánchez-Ortiga, Ruth |e verfasserin |4 aut | |
700 | 1 | |a Picó, Antonio M |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion |d 2008 |g 58(2011), 3 vom: 01. März, Seite 121-6 |w (DE-627)NLM190192887 |x 1579-2021 |7 nnns |
773 | 1 | 8 | |g volume:58 |g year:2011 |g number:3 |g day:01 |g month:03 |g pages:121-6 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.endonu.2010.12.002 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 58 |j 2011 |e 3 |b 01 |c 03 |h 121-6 |